Has Dana White confirmed he uses TRT?

White has publicly referenced using testosterone therapy as part of a medically supervised health protocol, confirmed in podcast and media appearances in 2023. He has not disclosed specific dosages, formulations, or lab results.

Is TRT the same as steroids?

Testosterone is an anabolic-androgenic steroid. TRT specifically refers to replacement dosing intended to restore levels to the normal physiologic range (roughly 300-1 to 000 ng/dL total testosterone). This differs from supraphysiologic "steroid cycles," which use doses several times higher than replacement and often stack multiple compounds. The clinical risk profile at replacement doses is substantially different from abuse-level dosing.

What blood tests should I get before starting TRT?

At minimum: total testosterone (drawn before 10 AM), free testosterone, sex hormone-binding globulin (SHBG), LH, FSH, estradiol, prolactin, complete blood count (CBC), comprehensive metabolic panel, and a lipid panel. PSA should be measured in men over 40 as a baseline. Two low readings on separate days are generally required before initiating treatment per Endocrine Society guidelines.

Can TRT alone cause the kind of body transformation Dana White showed?

TRT at physiologic replacement doses produces modest improvements in lean mass and fat reduction. A meta-analysis found average gains of about 1.6 kg lean mass over study periods. The scale of White's publicly visible transformation likely reflects concurrent caloric restriction, exercise programming, and potentially other interventions he has not detailed publicly.

Is TRT safe for men over 50 with heart disease risk?

The 2023 TRAVERSE trial found no increase in major cardiac events among high-risk hypogonadal men aged 45-80 on TRT over approximately 33 months. TRT does increase hematocrit, requiring regular monitoring. Men with recent cardiovascular events, uncontrolled heart failure, or untreated sleep apnea should discuss individual risk-benefit with their physician before starting.

Dana White and TRT: The Documented Public Record

By HealthRX Medical Team

Published May 25, 2026Updated May 25, 2026Last reviewed May 25, 2026

What Dana White Has Actually Said

Dana White, born in 1969, is the president of the Ultimate Fighting Championship and one of the most visible executives in combat sports. In late 2022, White disclosed that a physician told him he had approximately 10.4 years to live based on genetic testing results. That disclosure preceded a widely covered health overhaul.

By mid-2023, White's physical transformation was visible across press conferences and social media. He attributed much of the change to an 86-hour water fast, dietary restructuring, and what he described as working with "the best doctors in the world." In a January 2023 appearance on the Flagrant podcast, White confirmed he was receiving hormone optimization, referencing testosterone therapy among the interventions his medical team had prescribed.

White has not publicly named a specific testosterone formulation, dosage, or administration route. He has not disclosed bloodwork values or named his prescribing physician in connection with TRT specifically. What is on the public record: he has acknowledged using TRT as part of a broader medically supervised protocol.

What Remains Speculated

Several claims circulate online that go beyond what White has confirmed:

Specific compounds. Some commentators have speculated about testosterone cypionate or enanthate, but White has not named a formulation.
Growth hormone or peptide use. Speculation about concurrent HGH or peptide therapy is common in bodybuilding forums. White has not confirmed this.
Pre-transformation testosterone levels. No bloodwork has been shared publicly. Claims about his "before" levels are fabricated or assumed.

The HealthRX Medical Team emphasizes: physical changes visible in public appearances cannot be used to diagnose or confirm any specific pharmaceutical protocol. Muscle fullness, skin changes, and fat redistribution have dozens of potential explanations. Attributing a specific drug to a visual impression is clinically meaningless.

At a glance

Status: White has publicly referenced using TRT; specific protocol details are not publicly confirmed
Timeline: Health overhaul began late 2022 after a genetic longevity assessment; visible body changes through 2023 and 2024
Drug class: Testosterone replacement therapy (exogenous testosterone)
Clinical context: TRT is FDA-approved for diagnosed hypogonadism in men, with well-studied effects on body composition, energy, and cardiometabolic markers
What's missing: No public disclosure of dosage, formulation, or lab values

Clinical Context: TRT in Men Over 50

Testosterone levels in men decline at roughly 1-2% per year after age 30, a process sometimes called andropause or late-onset hypogonadism. By the time a man reaches his mid-50s (White's approximate age during his transformation), total testosterone may fall below the 300 ng/dL threshold that many endocrinologists use as a clinical cutoff.

The Endocrine Society's 2018 clinical practice guidelines recommend TRT only for men with confirmed low testosterone on at least two morning serum measurements, combined with symptoms such as decreased libido, fatigue, reduced muscle mass, or depressed mood. The guidelines explicitly caution against prescribing testosterone for age-related decline alone without symptomatic burden.

Formulations and Delivery

The most common TRT formulations include:

Testosterone cypionate or enanthate (intramuscular injection, typically 100-200 mg every 1-2 weeks)
Testosterone undecanoate (long-acting injection given every 10 weeks after loading)
Transdermal gels (1% or 1.62%, applied daily, delivering approximately 50-100 mg)
Testosterone pellets (subcutaneous implants lasting 3-6 months)

Each delivery method produces different pharmacokinetic profiles. Injections create peak-and-trough patterns; gels provide steadier levels but require daily application and carry transfer risk to household contacts.

Expected Effects on Body Composition

A meta-analysis published in Clinical Endocrinology found that TRT in hypogonadal men produced an average increase of 1.6 kg in lean body mass and a decrease of 1.6 kg in fat mass over treatment periods ranging from 3 to 36 months. These are modest but consistent effects. The dramatic recomposition White displayed publicly would be unusual from TRT alone and likely reflects concurrent dietary, exercise, and possibly other medical interventions.

Cardiovascular Considerations

TRT's cardiovascular profile has been debated for over a decade. The TRAVERSE trial, published in the New England Journal of Medicine in 2023, provided the largest randomized safety dataset to date. Among 5,246 men aged 45-80 with hypogonadism and preexisting or high risk for cardiovascular disease, testosterone treatment did not increase the incidence of major adverse cardiac events compared to placebo over a mean follow-up of 33 months.

This result was reassuring but not a blanket clearance. The trial excluded men with recent stroke, MI within 6 months, or uncontrolled heart failure. It also confirmed that TRT increases hematocrit (red blood cell concentration), which raises thrombotic risk and requires periodic monitoring.

Side Effect Profile

Common side effects of TRT include:

Erythrocytosis (elevated hematocrit), the most clinically significant risk, requiring regular CBC monitoring
Acne and oily skin
Testicular atrophy and reduced spermatogenesis (exogenous testosterone suppresses the HPG axis)
Sleep apnea exacerbation
Gynecomastia from peripheral aromatization of testosterone to estradiol
Mood changes, including irritability in some patients

The FDA requires a black box warning on testosterone products regarding the risk of abuse and dependence, as well as serious cardiovascular and hepatic adverse effects at supraphysiologic doses.

The UFC's Complicated History with TRT

White's personal relationship with TRT exists against a specific backdrop. The UFC allowed therapeutic use exemptions (TUEs) for testosterone until February 2014, when the Nevada State Athletic Commission banned TRT use by fighters. White himself publicly supported the ban, stating that fighters should not compete on TRT.

This created an irony that commentators have noted: the executive who championed banning TRT for athletes later acknowledged using it himself in a non-competitive context. The distinction is clinically valid. Therapeutic replacement to physiologic levels (targeting total testosterone of 450-700 ng/dL) is fundamentally different from supraphysiologic dosing for performance enhancement. The HealthRX Medical Team notes that conflating these two use cases is one of the most persistent misunderstandings in public TRT discourse.

The HealthRX Medical Team Take

White's public story is useful because it tracks a common clinical pattern: a man in his early-to-mid 50s receives a health wake-up call, undergoes comprehensive evaluation, and begins a medically supervised protocol that includes testosterone optimization alongside diet and lifestyle changes.

What makes this case instructive is also what makes it incomplete. White has been open about the broad strokes but has not disclosed the clinical details that would allow any outside evaluation of his protocol. That is his right. It also means that anyone attempting to replicate his results based on public information is working from an incomplete picture.

The HealthRX Medical Team recommends that men considering TRT based on celebrity transformations focus on three things: (1) get baseline labs including total and free testosterone, SHBG, LH, FSH, prolactin, estradiol, CBC, and a lipid panel, ideally on two separate mornings; (2) work with a board-certified endocrinologist or urologist, not a wellness clinic operating outside Endocrine Society guidelines; and (3) understand that TRT is a long-term commitment with required monitoring, not a short-term fix.

Frequently asked questions

›